Zoetis Inc. (ZTS) stock analysis

In our weekly check, Zoetis Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 2.

About Zoetis Inc.

Zoetis Inc. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in the United States, listed on NYSE as ZTS.

What our checks show for ZTS

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-11

Similar companies

HLN · VTRS · TEVA · TAK · ELAN · ALKS

Questions

What grade does Zoetis Inc. (ZTS) have?

In our weekly check, Zoetis Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of ZTS stock?

This week's biggest flags for Zoetis Inc.: High debt, Deep past fall, Weak revenue forecast. In total 5 of 25 checks show a warning or a red flag.

What does Zoetis Inc. do?

Zoetis Inc. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in the United States, listed on NYSE as ZTS.

When does Zoetis Inc. report earnings next?

The next earnings report is expected on 2027-02-11. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis